BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES...
BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

Merck is bucking the trend of its biopharma peers by continuing to invest in and build its infectious disease pipeline. With new regulatory pathways in play and novel funding mechanisms for antibiotics starting to take...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives...
BioCentury | Nov 19, 2018
Financial News

NASH company Genfit planning U.S. listing

As it prepares for a readout from a Phase III study of its lead candidate to treat non-alcoholic steatohepatitis, French bellwether Genfit S.A. (Euronext:GNFT) intends to conduct a listing on a U.S. exchange. Genfit said...
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | May 4, 2018
Financial News

A-Mansia raises €16M for the microbiome

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
BioCentury | Apr 27, 2018
Financial News

Microbiome company A-Mansia secures €16M

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES...
Items per page:
1 - 10 of 29
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES...
BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

Merck is bucking the trend of its biopharma peers by continuing to invest in and build its infectious disease pipeline. With new regulatory pathways in play and novel funding mechanisms for antibiotics starting to take...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives...
BioCentury | Nov 19, 2018
Financial News

NASH company Genfit planning U.S. listing

As it prepares for a readout from a Phase III study of its lead candidate to treat non-alcoholic steatohepatitis, French bellwether Genfit S.A. (Euronext:GNFT) intends to conduct a listing on a U.S. exchange. Genfit said...
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives...
BioCentury | May 4, 2018
Financial News

A-Mansia raises €16M for the microbiome

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
BioCentury | Apr 27, 2018
Financial News

Microbiome company A-Mansia secures €16M

...close of a tranched series A round led by Seventure Partners with participation from Fonds Vives...
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES...
Items per page:
1 - 10 of 29